Jacob Joseph, MD
P. Jacob Joseph, M.D., is the Medical Director of the International Program at TIRR Memorial Hermann, the Clinical Chief for Specialty Rehabilitation Programs at TIRR Memorial Hermann and he is the Vice Chair of Clinical Operations for Physical Medicine and Rehabilitation at the McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).
Dr. Joseph joined the medical staff at TIRR Memorial Hermann after completing his residency at The University of Washington in Physical Medicine and Rehabilitation in June 2010. He received his medical degree in 2006 at UTHealth Medical School and completed internship and residency at the University of Washington in Seattle.
Dr. Joseph is an assistant professor of physical medicine and rehabilitation at McGovern Medical School at UTHealth. As an attending physician at TIRR Memorial Hermann, Dr. Joseph’s primary focus is on caring for patients recovering from traumatic brain injury and neurotrauma. His clinical and research interests include spasticity management and electrodiagnostic medicine. He is a member of the American Academy of Physical Medicine and Rehabilitation and the Association of Academic Physiatrists.
Mya Schiess, MD
Dr. Mya Schiess is Professor of Neurology at the University of Texas-Houston School of Medicine and Vice Chair of the department. She also serves as Director of the Movement Disorders clinic and fellowship program. Her hospital appointments include Hermann Memorial, LBJ- Harris County Hospital, TIRR and Methodist in Houston.
Dr. Schiess completed the MD program at the University of New Mexico, followed by a residency in Neurology at The University of Texas Health Science Center Southwestern in Dallas, where she also completed a research fellowship in neurophysiology and pharmacology.
Dr. Schiess was honored as recipient of The Adriana Blood Endowed Chair in Neurology. She has served as co- or principal-investigator for multiple studies and currently her central research endeavors are focused on identifying the pathophysiology of Parkinson disease, identifying reliable biomarkers early in the disease process, and in developing effective neuroprotective therapies. Among her other areas of ongoing research are the role of deep brain stimulation on cognitive function and slowing disease progression, the role of neuropeptides and cytokines in neurodegeneration and the development of classification criteria for subtypes of Parkinson disease.
Dr. Schiess is on the Editorial Board for Archives of Neurology. Some of her recent publications are as co-author of the chapter "Rehabilitation of persons with Parkinson's disease and other movement disorders", in Rehabilitation Medicine: Principles and Practice,2005; Dissociating Cognitive Deficits involved in voluntary eye movement dysfunctions in Parkinson’s disease patients, Neuropsychologia, 2006; Consensus Panel Recommendations for the Use of Intrathecal Baclofen Therapy in Post-Stroke Spastic Hypertonia, Topics in Stroke Rehabilitation, 2006; Levodopa slows prosaccades and improves antisaccades : An eye movement study in Parkinson’s Disease, Journal of Neurology, Neurosurgery and Psychiatry, 2007; “Serum Uric Acid and Parkinson Disease: Potential Biomarker for Nigrostriatal Failure” Archives of Neurology, 2008.
Joseph Jankovic, M.D.
Joseph Jankovic, M.D. is Professor of Neurology, Distinguished Chair in Movement Disorders, and Founder and Director of the Parkinson's Disease Center and Movement Disorders Clinic (PDCMDC), Department of Neurology, Baylor College of Medicine, Houston, Texas. Under the direction of Dr. Jankovic the PDCMDC has been recognized as "Center of Excellence" by the Parkinson’s Foundation, the Huntington Disease Society of America, and the Tourette Association of America.
Past president of the International Parkinson and Movement Disorder Society and of the International Neurotoxin Association, Dr. Jankovic has been recognized as an Honorary Member of the American Neurological Association, Australian Association of Neurologists, French Neurological Society, and the International Parkinson’s Disease and Movement Disorders Society. Selected as a “Great Teacher” by the National Institute of Health, Dr. Jankovic is the recipient of many awards including the American Academy of Neurology (AAN) Movement Disorders Research Award, First National Parkinson Foundation (NPF) Distinguished Service Award, Huntington’s Disease Society of America Guthrie Family Humanitarian Award, Tourette Syndrome Association Lifetime Achievement Award, Dystonia Medical Research Foundation Distinguished Service Award, Texas Neurological Society Lifetime Achievement Award, Baylor College of Medicine Alumni Association Distinguished Faculty Award, Fulbright & Jaworski Faculty Excellence Award, and the Baylor College of Medicine Master Clinician Lifetime Award. Since 2001, he has been listed among “Highly Cited Researchers” earning him and H-Index of 141, and in 2015, he was selected among “World’s Most Influential Scientific Minds”. Dr. Jankovic has contributed to classifications, characterization, and therapeutic guidelines of various movement disorders. He has served as the principal investigator in hundreds of clinical trials and his pioneering research on drugs for parkinsonian disorders and hyperkinetic movement disorders, including botulinum toxin and tetrabenazine, has led to their approval by the Food and Drug Administration. Dr. Jankovic has published over 1,200 original articles and over 50 books, including several standard textbooks such as “Neurology in Clinical Practice” and “Principles and Practice of Movement Disorders”.
Erin Furr-Stimming, MD
Erin Furr Stimming received her MD from The Chicago Medical School. She completed her internship, Neurology residency and Movement Disorders fellowship at the University of Texas Health Science Center – Houston/UT Health.
She is an Associate Professor in the Department of Neurology (Movement Disorders Division) at UT Health - Houston. She is the Chief of Neurology at Lyndon Baines Johnson General Hospital and the director of the Neurology Clerkship as well as the Co-Director of the Movement Disorders Fellowship at UT.
Erin is actively involved in multiple educational committees at UT as well as committees within the Harris Health System. She has received the Deans Teaching of Excellence Award several times and offers lectures to the medical students and residents on a regular basis. Erin recently received the Emerging Leadership Award given by the Harris Health System.
Erin volunteers in the community offering lectures to nonprofit Parkinson’s support groups and Huntington’s support groups. She is an active participant on the board of the local Huntington’s Disease Society of America (HDSA) affiliate and on the medical advisory board of Houston Area Parkinson’s Society (HAPS).
Her areas of interests lie in student and resident medical education, clinical research focused on early diagnostic markers of Parkinson’s disease, neuroregenerative therapy for neurodegenerative diseases such PD and HD, basic research focused on further understanding the huntingtin protein and clinical research focused on improved treatments for patients with Huntinton’s diseaese. She is the director of the Huntington’s disease clinic at UT Health - Houston. Erin is the site PI on several clinical trials for patients with Parkinson’s disease and Huntington’s disease.
Joohi Shahed-Jimenez, MD
Joohi Jimenez-Shahed, MD is an Assistant Professor of Neurology at Baylor College of Medicine (BCM) where she currently is the Director of the Deep Brain Stimulation program. After completing her undergraduate degree at Washington University in St. Louis, she received her medical degree from BCM and Neurology residency training at Duke University Medical Center. She then completed a fellowship in Movement Disorders at the Parkinson’s Disease Center and Movement Disorders Clinic (PDCMDC) at BCM. Her research interests lie in investigating the intraoperative neurophysiology of patients undergoing DBS for movement disorders. Dr. Jimenez-Shahed serves as co-chair of the Functional Neurosurgical Working Group of the Parkinson Study Group. She is also an investigator with the Huntington Study Group, Clinical Research Consortium for Spinocerebellar Ataxias, Dystonia Coalition and TSA International Database of DBS Studies in Tourette Syndrome. She serves on the Science Advisory Board of the Davis Phinney Foundation and the Medical Advisory Board for the Tourette Association of America. She has served as Principal Investigator for both industry- and investigator-sponsored clinical trials and has authored several papers and book chapters. She is the recipient of the Roy H. Cullen Quality of Life Award (Houston Area Parkinson Society), the Rising Star Clinician Award (BCM), and the Fulbright & Jaworski L.L.P. Faculty Excellence Award in Teaching and Evaluation (BCM).
Eugene Lai, MD, PhD
Dr. Eugene Lai is Professor of Neurology and Neuroscience at the Weill Cornell Medical College and the Houston Methodist Neurological Institute. He holds the Robert W. Hervey Distinguished Endowed Chair for Parkinson’s Disease Research and Treatment. He is also the Director of the Neurodegenerative Diseases Clinic.
Dr. Lai received his bachelor degree in Biochemistry from the University of Wisconsin and his doctorate degree, also in Biochemistry, from the University of Washington. He conducted research in molecular and cellular biology. He then studied medicine at Baylor College of Medicine and completed his Neurology residency training at Baylor Affiliated Hospitals in Houston.
Dr. Lai is a clinician-scientist who has special interests in the causes and treatments of neurodegenerative diseases, such as Parkinson’s disease, Alzheimer's disease, Amyotrophic Lateral Sclerosis and other related disorders. He is the principal investigator or co-investigator of many clinical research studies. He has authored more than one hundred peer-reviewed scientific publications and book chapters, and has lectured widely on topics in neurodegenerative diseases. He also enjoys teaching medical students, residents and fellows in his clinical practice. He has been voted “Best Teacher” by his neurology residents.
Dr. Lai is a member of Medical Advisory Board and a past Executive Board member of the Houston Area Parkinson Society. He is the past President of the Houston Neurological Society and has also served as the Vice-President of the Texas Neurological Society. He has been recognized as one of American’s Top Physicians, Texas Super Doctors and Houston Super Doc.
Lisa Musgrave, BSN, MHA, RN
Lisa Musgrave is the Vice President of Home Based Care for Memorial Hermann Health System. Lisa is responsible for the leadership and development of the system’s home care programs which include home health, hospice, home medical equipment and respiratory therapy, sleep labs and in fall 2017 the opening of home infusion services. Home Based Care serves over 2,000 patients a day throughout the Houston metropolitan area.
Prior to coming to Memorial Hermann, Lisa was the Chief Nursing Officer/Operations Officer for Home Health and Hospice at Intermountain Homecare a Division of Intermountain Health System. She oversaw the state’s largest home health and hospice provider with 12 locations throughout Utah and Idaho providing care to infants, children, adults, seniors and their families.
Lisa is a registered nurse with over 20 years of health care leadership with an emphasis in community based care and population health. She enjoys working within systems, creating partnerships and smoothing transitions for patients and their families. Her passion is keeping patients in their home and helping patients have their best possible day every day. Lisa has served on the Missouri State Home Care Board and was a volunteer on the Board with Meals on Wheels.
Lisa earned her Bachelor of Science Degree from William Jewell College and her Master’s in Healthcare Administration from Ohio University.
Heather Smith, MA, CCC/SLP
Heather M. Smith, MA, CCC/SLP is currently a senior speech language pathologist at the TIRR Memorial Hermann Outpatient Rehabilitation Clinic at Memorial City. She is one of the lead therapists providing mentoring, guidance, and collaboration with other speech language pathologists across the sites. Heather has 13 years of experience as speech language pathologist and has an extensive background in the evaluation and treatment of patients with Parkinson’s Disease and Movement Disorders across the continuum of care. She is certified in Lee Silverman Voice Treatment (LSVT)-LOUD and is proficient in Modified Barium Swallow Studies, McNeil Dysphagia Treatment, Flexible Fiberoptic Nasoendoscopy among others.